drugset / Trial / NCT00418457

Regional Anesthesia and Breast Cancer Recurrence

NCT00418457

Phase 3 Completed 2108 enrolled The Cleveland Clinic
RandomizedParallel-groupOpen-labelPrevention

Summary

In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be followed for up to 10 years to determine the rate of cancer recurrence or metastasis.

Timeline

Start
2007-01
Primary completion
2018-02
Completion
2019-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Comparator Sevoflurane Other / unclassified

Indications